Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001349929-16-000089)

Filing Details

Accession Number:: 0001349929-16-000089
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-05-26 17:19:56
Reporting Period:: 2016-05-25

Filing Date:: 2016-05-26
Accepted Time:: 2016-05-26 17:19:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1349929	Cancer Genetics Inc	CGIX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
897464	John Pappajohn	201 Route 17 North 2Nd Floor Rutherford NJ 07070		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	Acquisiton	2016-05-25	317,820	$0.00	2,099,609	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, Par Value $0.0001 Per Share	Warrant (right to buy)	Acquisiton	2016-05-25	158,910	$0.00	158,910	$2.25

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
158,910	2016-11-25	2021-11-25	No	4	P	Direct

Footnotes

The reported securities were purchased in a registered direct offering and a concurrent private placement, both of which closed on May 25, 2016.
The reported securities consist of one share of common stock, par value $0.0001 per share (the "Common Stock") and a warrant to purchase one-half of a share of Common Stock. The purchase price for the reported securities was $2.2025 per share and warrant.